Search results
Advanced RNA Sequencing Reveals the Drivers of New COVID Variants
SciTechDaily· 6 days agoThe SARS-CoV-2 virus that causes COVID has the unsettling ability of often generating variants of...
Kinetics of Hepatitis E Virus Infections in Asymptomatic Persons
Centers for Disease Control and Prevention· 1 day agoHepatitis E virus (HEV; family Hepeviridae), is a single-stranded positive-sense RNA virus with 3 open reading frames (1). Although infections with HEV-1 and HEV-2 are endemic ...
Bird flu virus has been spreading in US cows for months, RNA reveals
Nature· 22 hours agoGenomic analysis suggests that the outbreak probably began in December or January, but a shortage of...
Ipsen, Skyhawk to develop RNA-targeting pills for rare brain diseases
BioPharma Dive via Yahoo Finance· 5 days agoDive Brief: French pharmaceutical company Ipsen will work with privately held biotechnology company...
RNA Modification Behind Disruption of Mitochondrial Protein Synthesis in Alzheimer’s
Technology Networks· 2 days agoA team of researchers at Johannes Gutenberg University Mainz (JGU) has identified a mechanism that...
Getting dynamic information from static snapshots
Phys.org· 9 hours agoIn a paper published today in Proceedings of the National Academy of Sciences, researchers from the UChicago Pritzker School of Molecular Engineering and...
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
Morningstar· 5 days ago...Netherlands & CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it will present new preclinical data for its proprietary Axiomer™ RNA editing technology...
J.W. Cole Advisors Inc. Makes New $283,000 Investment in Avidity Biosciences, Inc. (NASDAQ:RNA)
ETF DAILY NEWS· 2 days agoJ.W. Cole Advisors Inc. bought a new position in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) in the fourth quarter, according to the company in its most ...
Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological...
WDTN-TV 2 Dayton· 6 days agoIpsen (Euronext: IPN; ADR: IPSEY) and Skyhawk Therapeutics today announced the signing of an exclusive worldwide collaboration to discover and develop novel small molecules that modulate < ...
Cows' milk particles used for effective oral delivery of drugs
Phys.org· 3 days agoRibonucleic acid (RNA) therapies are a powerful new class of drugs that offer a way to target...